CanDiag Raises $500K for Breast-Cancer Diagnostics

CanDiag Inc., a clinical research start-up focused on developing diagnostics for early-stage breast cancer detection, said it has raised funding of more than $500,000 from an angel syndicate.

According to the terms of the financing, the angel syndicate has the option of making an additional investment of more than $1 million within the next year, the company said in a news release. Further financial terms of the investment weren't disclosed.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.